Johanne U Hermansen

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.

|Jul 23, 2025
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Johanne U Hermansen, Paschalis Athanasiadis, Yanping Yin

|Jan 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast

|May 20, 2024
Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery.

Johanne U Hermansen, Yanping Yin, Idun Dale Rein

|Dec 01, 2023
Standardized assays to monitor drug sensitivity in hematologic cancers.

Pilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto

|Sep 20, 2021
The Norwegian childhood cancer biobank.

Johanne U Hermansen, Dorota M Wojcik, Nina Robinson

Pageof 1

Frequent Collaborators

5 joint publications

Sigrid S Skånland

2 joint publications

Idun Dale Rein

2 joint publications

Tero Aittokallio

2 joint publications

Arnon P Kater